NOVARTIS FDA Approval NDA 021598

NDA 021598

NOVARTIS

FDA Drug Application

Application #021598

Documents

Letter2003-10-03
Letter2011-10-12
Label2003-04-17
Label2003-10-10
Label2004-05-03
Letter2003-05-29
Letter2003-10-03
Letter2004-04-20
Letter2004-07-01
Label2003-10-10
Label2004-07-01
Label2011-10-12
Review2005-04-08
Letter2017-03-20
Label2017-03-21
Pediatric Medical Review1900-01-01
Pediatric DD Summary Review1900-01-01
Label2020-05-12
Letter2020-05-13
Letter2020-06-03
Label2020-06-05

Application Sponsors

NDA 021598NOVARTIS

Marketing Status

Prescription001

Application Products

001SOLUTION/DROPS;OPHTHALMICEQ 0.5% BASE1VIGAMOXMOXIFLOXACIN HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2003-04-15STANDARD
LABELING; LabelingSUPPL2AP2004-04-12STANDARD
LABELING; LabelingSUPPL5AP2003-10-03STANDARD
LABELING; LabelingSUPPL8AP2004-06-25STANDARD
LABELING; LabelingSUPPL17AP2011-10-07UNKNOWN
LABELING; LabelingSUPPL22AP2017-03-14STANDARD
LABELING; LabelingSUPPL23AP2020-05-11STANDARD
LABELING; LabelingSUPPL24AP2020-06-02STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL2Null9
SUPPL17Null7
SUPPL22Null7
SUPPL23Null15
SUPPL24Null15

TE Codes

001PrescriptionAT1

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21598
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.